An interventional study of Liquid Phase Concentrated Growth Factor and Conventional arthrocentesis in Temporomandibular Disorders (TMD), Internal Derangement of the Tempromandibular Joint and Anterior Disc Displacement, sponsored by Horus University. Recruiting at 1 site in Egypt. Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-08-17.
Sponsored by Horus University · Not applicable, Interventional, and Treatment
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 63 studies in Temporomandibular Joint Disorders with a site in Egypt — 10 open to participants now, 14 under way, none of them phase 3. Temporomandibular Joint Disorders · Egypt.
Among the 63 studies in Temporomandibular Joint Disorders with a site in Egypt, this one is the 21st largest by planned enrollment of the 49 interventional ones that give a count, is one of 8 that started in 2025, is one of 42 with no phase, reaches primary completion later than 9 of the 13 other live ones, and was the 45th registered.
593 studies on the registry are indexed under Temporomandibular Joint Disorders; 149 are open to participants now.
Browse Temporomandibular Joint Disorders studies →10 of the 63 studies in Temporomandibular Joint Disorders with a site in Egypt are open now. Recruiting first, the newest first:
Cairo University · Sites in Egypt
Ages 18–65
Future University in Egypt · Sites in Egypt
Ages 18–60
Nourhan M.Aly · Sites in Egypt
Ages 20–40
Cairo University · Sites in Egypt
Ages 18–40
Basel khaled mohamed · Sites in Egypt
Ages 18–100
A study can be open while its sites in Egypt have not opened yet or have stopped. Only those recruiting at a site in Egypt →
Of the 76 Temporomandibular Joint Disorders studies recruiting now, 26 (34%) set no upper age limit and 46 (61%) stop at 75 or younger; 7 take children under 18; 23 take healthy volunteers.
This study: 18 Years to 45 Years · all sexes · healthy volunteers too.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
63 studies; the count open now beside each. This study's row is marked.
A study in two phases is counted once above. Listed by phase, each with its combined phases: Phase 1 3 · Phase 2 3 · Phase 4 2
First in 2016; this study’s year is marked. 8 started in 2025.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 32 is below the median of 45 across 417 interventional studies indexed under Temporomandibular Joint Disorders.
Median enrollment 30 across the 49 interventional studies, 88 across the 14 observational. Of the 42 that completed or were terminated, 1 (2%) have results posted.
This tab as a report to print or save as PDF → With an account.
None of the 63 has an industry lead sponsor. The 10 most frequent:
Horus University is the lead sponsor of 33 studies on the registry; 11 are open to participants now.
Horus University has 1 study filed under Temporomandibular Joint Disorders — fewer than ten, so there is no comparison to draw.
4 of the studies in Temporomandibular Joint Disorders with a site in Egypt that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT07878247Future University in EgyptClinical and Electromyographic Assessment of Occlusal Splint Therapy | 2026-12-01 |
| NCT07626164Alexandria UniversityThree Photobiomodulation Wavelengths (635, 940, and 1064 nm) on Chronic Myogenic Temporomandibular Disorder | 2026-12-30 |
| NCT07614932Cairo UniversityArthroscopic Lysis and Lavage With and Without Intra-articular Injection of Hyaluronic Acid in Patients With DDwoR in TMJ | 2027-01 |
| NCT07486609Cairo UniversityDiagnostic Study Accuracy of Jaw Motion Analyzer(JMA) Versus Research Diagnostic Criteria(RDC/TMD) and Magnetic Resonance Imaging(MRI) for Temporomandibular Disorders Among Patients With Chronic Orofacial Pain. | 2027-01-01 |
Add all 4 to your calendar (.ics) → With an account.
Among the 63 studies in Temporomandibular Joint Disorders with a site in Egypt, from their registry updates:
This tab as a report to print or save as PDF → With an account.
This study aims to rigorously assess the effectiveness of LPCGF in the management of internal disc displacement in patients with TMD through a randomized clinical trial. By comparing LPCGF therapy with conventional arthrocentesis, this research looks to provide robust evidence on the efficacy, safety, and potential role of (LPCGF) as an alternative therapeutic choice for IDD.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
Underlined terms in the criteria open these too. Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
ASA physical status
The anaesthetists’ scale of health before surgery: I is healthy, II has a mild illness that is under control, III a severe one, IV a severe illness that is a constant threat to life. V and VI are used for the critically ill and for organ donors.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Autoimmune disease
A condition in which the immune system attacks the body’s own tissues, such as rheumatoid arthritis, lupus, psoriasis, type 1 diabetes or inflammatory bowel disease.
Immunotherapy studies often leave out active autoimmune disease, and some name exceptions, such as thyroid disease on replacement hormone. Check the exceptions this study lists.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
Contraindication
A reason a treatment, test or procedure should not be given to a particular person, such as an allergy, another illness or a medicine they take.
Explained by clinicaltrials.gg, not part of the registry record. The study team decides who can take part.
16 patients have anterior disc displacement with or without reduction will be treated with injection of liquid phase concentrated growth factor
Procedure: Liquid Phase Concentrated Growth Factor
16 patients have anterior disc displacement with or without reduction will be treated with conventional arthrocentesis
Procedure: Conventional arthrocentesis
16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with injection of liquid phase concentrated growth factor
16 patients with anterior disc displacement with or without reduction randomly allocated to be treated with conventional arthrocentesis
Assess and comparing the pain of both groups
measured using the Visual Analog Scale (VAS), ranging from 0 (no pain) to 10 (worst pain)
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention.
Assess and comparing the mouth opening of both groups
measured in millimeters (Maximum inter-incisal opening measured by the distance in millimeters between the incisal edges of the upper and lower central incisors in vertical direction at maximum pain free mouth opening) by using caliper. and comparing the results of both groups
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention.
Joint sounds
(clicking and crepitus) evaluated by clinical examination; presence of joint noise at opening and closing was evaluated by light bilateral digital palpation during jaw movement.
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention.
Mandibular deviation during mouth opening.
By clinical examination , observe mandibular deviation toward right or left side or deflection during opening and closing the mouth
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention.
Lateral and protrusive movements
(Range of lateral and protrusive movements measured by the distance in millimeters between the upper and lower midlines in horizontal direction on lateral and protrusive movements by using caliper).
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention
tenderness on palpation
Presence or absence of joint tenderness on palpation: recorded as tender or not tender.
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention.
TMD symptoms
TMD symptoms were evaluated using Modified Helkimo Index
Time frame: Assessed at baseline (before treatment),1week, 1 month, 3 months, and 6 months after the intervention.
Plan to share: No
No publications or documents are linked to this record.
Started Oct 2025 (actual). Primary completion is estimated for Nov 2026, 13 months after the start.
Of 244 non-industry interventional studies with no phase under Temporomandibular Joint Disorders, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 5 and three quarters within 21. This study's planned 13 months is above that.
Counting every sponsor, half of 248 studies reached it within 11 months; a quarter within 5 and three quarters within 21.
How these figures are worked out, and which studies are left out of them.
Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.
Contact study teamGet an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Temporomandibular Joint Disorders →
Horus University